Sage Journals: Discover world-class research

Retricted access

Research article

First published 2019-3

Opportunities and Challenges of Multinational Pharmaceutical Enterprises in Transforming Pharmaceutical Market in China

Linfeng Hu, Zhong Yu, Qingwen Yuan [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2000-8

Public Policy and the Role of Multinationals and Local Enterprises in the Indian Drugs and Pharmaceuticals Industry

Pradeep Kanta Ray, Shams Ur-Rahman

Global Business Review

Retricted access

Research article

First published 1978-3

Multi-National Enterprise in Pharmaceutical Industry and Less Developed Countries

P. G. K Panikar

The Indian Economic Journal

Retricted access

Research article

First published 2016-6

Cross-border Acquisitions and Host Country Determinants: Evidence from Indian Pharmaceutical Companies

Bhargavi Jayanthi, S.N.V. Sivakumar, Arunima Haldar

Global Business Review

Retricted access

Research article

First published 1976-4

An Analysis of the Medical Supply Industries

Meredeth Turshen

International Journal of Social Determinants of Health and Health Services

Retricted access

Research article

First published 2026-1

Making Global Pharma Supply Chain Resilient: Will the PLI Scheme of India make it a Reliable Alternative to China for the Supply of APIs?

Reji K. Joseph, Ramaa Arun Kumar

The Indian Economic Journal

Retricted access

Research article

First published 2024-7

Do Supply Chain Performance Influence Firm Profitability? A Predictive Approach in the Context of the Indian Pharmaceutical Industry

Saswati Tripathi, Bijoy Talukder, Krishnamachari Rangarajan

IIM Kozhikode Society & Management Review

Retricted access

Research article

First published 2024

Assessing Productivity Dynamics in the Indian Pharmaceutical Industry: A Comparative Analysis of the Foreign and the Domestic Ownership Influences

Madan Dhanora, Mohd Shadab Danish

Millennial Asia

Open access

Research article

First published 2024-10

The impact of home and host country institutional development on multinationals’ R&D intensity

Pia Ellimäki, Nuria Esther Hurtado-Torres, Eulogio Cordón-Pozo

BRQ Business Research Quarterly

Retricted access

Research article

First published 2007-7

Is There a Price to Pay for Short-Term Savings in the Clinical Development of New Pharmaceutical Products?

Shelby D. Reed, Robert M. Califf, Kevin A. Schulman

Therapeutic Innovation & Regulatory Science

Search results